Literature DB >> 17662550

Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay.

Jessica R Cummings1, Ginger R Jamison, Jan W Boudreaux, Merry J Howles, Thomas J Walsh, Randall T Hayden.   

Abstract

The Aspergillus galactomannan enzyme-linked immunosorbant assay (EIA) has been demonstrated to facilitate rapid and sensitive detection of invasive aspergillosis. However, test specificity has not been fully evaluated in non-Aspergillus fungal species. Of 53 fungal isolates, cross-reactivity was observed with 5 non-Aspergillus spp.: Blastomyces dermatitidis, Nigrospora oryzae, Paecilomyces lilacinus, Penicillium chrysogenum, and Trichothecium roseum.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17662550     DOI： 10.1016/j.diagmicrobio.2007.04.022

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  27 in total

1.  Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay.

Authors:  Anna Maria Tortorano; Maria Carmela Esposto; Anna Prigitano; Anna Grancini; Cristina Ossi; Caterina Cavanna; Giuliana Lo Cascio
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Caspofungin: cross-reactivity in the Aspergillus antigen assay.

Authors:  J Steinmann; J Buer; P-M Rath
Journal:  J Clin Microbiol       Date:  2010-03-31       Impact factor: 5.948

3.  Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage fluid from a patient with an invasive infection due to Lichtheimia ramosa.

Authors:  Rafael Borrás; Patricia Roselló; Marifina Chilet; Dayana Bravo; Juan García de Lomas; David Navarro
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

4.  Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients.

Authors:  M Aigner; M Wanner; P Kreidl; C Lass-Flörl; M Lackner
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

5.  Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients.

Authors:  Johan Maertens; Griet Huysmans; Koen Theunissen
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

6.  Galactomannan testing for early diagnosis of Exserohilum rostratum infection.

Authors:  Maya Korem; Itzhack Polacheck; Ayelet Michael-Gayego; Jacob Strahilevitz
Journal:  J Clin Microbiol       Date:  2013-05-29       Impact factor: 5.948

Review 7.  Respiratory Mycoses in COPD and Bronchiectasis.

Authors:  Pei Yee Tiew; Micheál Mac Aogáin; Soo Kai Ter; Stefano Aliberti; James D Chalmers; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2021-03-11       Impact factor: 2.574

8.  Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.

Authors:  Gemma L Johnson; Shah-Jalal Sarker; Francesco Nannini; Arianna Ferrini; Emma Taylor; Cornelia Lass-Flörl; Wolfgang Mutschlechner; Stephen A Bustin; Samir G Agrawal
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

Review 9.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 10.  Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach.

Authors:  S Moura; L Cerqueira; A Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-13       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.